ProQR Therapeutics
PRQR
77 hedge funds and large institutions have $118M invested in ProQR Therapeutics in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 8 closing their positions.
388% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 8
271% more capital invested
Capital invested by funds: $31.7M → $118M (+$86M)
183% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 6
82% more call options, than puts
Call options by funds: $296K | Put options by funds: $163K
64% more funds holding
Funds holding: 47 → 77 (+30)
21.69% more ownership
Funds ownership: 21.36% → 43.05% (+22%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$19M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$11.3M |
| 3 |
AAA
Affinity Asset Advisors
New York
|
+$8.97M |
| 4 |
Millennium Management
New York
|
+$8.52M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$3.34M |
| 2 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$2.05M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$880K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$750K |
| 5 |
Two Sigma Advisers
New York
|
-$185K |
PRQR Hedge Fund Activity: Q4 2024 in Review
77 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q4 2024, worth a combined $118M — up 271% from $31.7M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new PRQR positions and 8 closed out — a net gain of 31 holders — while 17 added to existing stakes and 6 trimmed.
The largest buyer was Adage Capital Partners, adding an estimated $19M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $3.34M sold.
- 77 institutional investors held ProQR Therapeutics (PRQR) as of Q4 2024, up from 47 in Q3 2024.
- Funds reported $118M of ProQR Therapeutics stock for Q4 2024, up 271% quarter-over-quarter.
- 39 funds opened new ProQR Therapeutics positions in Q4 2024 and 8 closed out, a net change of +31 holders.
- The largest ProQR Therapeutics buyer in Q4 2024 was Adage Capital Partners, an estimated $19M added.
- The largest ProQR Therapeutics seller in Q4 2024 was EcoR1 Capital, an estimated $3.34M sold.
Based on aggregated 13F filings for Q4 2024.